P r a c tic e I nte g r at io n & L ife lo n g L e a r nin g
H OW CO M M O N I S TH I S I N M Y PR AC TI CE? What is urinary incontinence?
Urinary incontinence is the involuntary loss of urine resulting from pathologic, anatomic or physiologic factors. The two major types of urinary incontinence are stress and urge incontinence.
Stress urinary incontinence (SUI) involves the loss of small quantities of urine during an increase in intra-abdominal pressure, which is produced by coughing, sneezing, laughing or exercising. SUI is characterised by outlet incompetence. Urge urinary incontinence (UI) involves urine loss due to abnormal detrusor muscle contractions and is, to some degree, associated with urinary retention. UI is a major component of overactive bladder syndrome, and is characterised by an abrupt and strong desire to void.
Other types of urinary incontinence include overflow, functional and mixed. Overflow incontinence involves a variety of symptoms such as urgency, frequent urination and constant dribbling, and is characterised by urine loss due to overdistension and ineffective emptying of the bladder. Functional incontinence refers to the inability to get to the toilet in time due to acute or chronic physical or mental impairment. Mixed urinary incontinence is the term used to describe the condition in which the symptoms of both SUI and UI are present.
How relevant is this to my practice?
The prevalence of urinary incontinence in Singapore has been reported to range from 4.6%
(1) to 14.5%. (2) However, this rate might arise from significant underreporting in the community, as institutional studies often report a higher prevalence.
As patients rarely initiate a discussion on urinary continence, the onus is on the astute clinician to elicit information, such as symptoms suggestive of urinary incontinence, from their highrisk patients. 
WH AT CA N M Y PR AC TI CE D O? Actively screen high-risk patients
Clinicians can screen high-risk patients for symptoms of urinary incontinence during the course of regular clinical consultation.
An opening question from the clinician typically gives most patients the nudge they need to tell the clinician more about their condition. Depending on the patient's duration and severity of symptoms, as well as predisposing risk factors, the consultation can progress to either identify reversible causes (DIAP(P)ERS; Table I ( 4) ), especially in the geriatric population, or discuss further investigation and management options. A review by Weiss outlines the drugs that can cause or contribute to urinary incontinence (Table II) . (5) As with many urological conditions, quick surveys on how the patient or caregiver is coping with the symptoms and the level of inconvenience experienced by either party are equally 
Managing urinary incontinence in the community

Review medication records
A review of the patient's current prescription medications, especially cardiology and antihypertensive agents, and all supplements, including alternative medications or herbal treatments, should be done. Medications such as diuretics, which may worsen incontinence (Table II (5) ), should be reviewed for their indications, and the introduction of a substitute considered. (4) ).
SO M E U S E FU L I N V E S TI G ATIO N S
Cause Notes Delirium
Results from medical illness or medication. Incontinence is secondary and abates when the cause of delirium has been corrected.
Infection (urinary)
Asymptomatic bacteriuria does not usually cause incontinence.
Atrophic urethritis May cause or contribute to incontinence. Vaginitis responds to topical oestrogen therapy.
Pharmaceuticals
Many drugs can cause or contribute to incontinence (see Table II ), including non-prescribed agents.
Psychological
Severe depression is rarely the cause of incontinence.
Excessive urine output
Results from large fluid intake, consumption of diuretic agents, metabolic disorders (e.g. hyperglycaemia, hypercalcaemia). Nocturnal incontinence may result from the mobilisation of fluid from peripheral oedema.
Restricted mobility Often results from overlooked, correctable causes such as arthritis, postural hypotension or fear of falling.
Stool impaction Disimpaction restores continence. ). Nevertheless, the best prevention for urinary incontinence is healthy weight management. Maintaining an optimum weight may decrease urinary incontinence, secondary to decreases in pressure exerted on the bladder and urethral mobility.
Drug class Mechanism of incontinence
Cause overflow incontinence
Anticholinergics • Antidepressants Decreased bladder contractions with retention • Antipsychotics Decreased bladder contractions with retention • Sedative-hypnotics Decreased bladder contractions with retention • Antihistamines Decreased bladder contractions with retention CNS depressants • Narcotics Decreased bladder contractions with retention • Alcohol Decreased bladder contractions with retention • Calcium channel blockers Decreased bladder
N O N -PH A R M ACO LO G IC TH ER A PY
PH A R M ACO LO G IC TH ER A PY
Pharmacologic therapy should be used in conjunction with non-pharmacologic therapy.
Pharmacologic options for stress incontinence
Localised oestrogen replacement therapy may be considered if menopause or other relative oestrogen deficiency is identified as the main cause of urinary incontinence in females with SUI.
Topical oestrogen such as vaginal oestrogen may be inserted as a pessary every three months. Alternatively, an oestrogen cream can be applied three times a week. The prescribed dose should be initiated at the smallest recommended dose and slowly titrated upward, based on patient response and tolerance.
What are Kegel exercises?
These are exercises designed to strengthen the pelvic muscles and are named after Dr Kegel, who developed the exercise. The goal of Kegel exercises is to tighten the major muscles that stretch across the pelvic floor.
It is important to activate the right muscles. The following are methods to confirm that the right muscles are used:
1. Try to stop the flow of urine when you are passing urine in the toilet. If you can do it, you are using the right muscles. 2. Imagine that you are trying to stop passing gas. Squeeze the muscles you would use. If you sense a 'pulling' feeling, those are the right muscles to be used during pelvic exercises.
Important points to remember
• Don't squeeze other muscles at the same time. Be careful not to tighten your stomach, legs or other muscles, as squeezing the wrong muscles can put more pressure on your bladder control muscles. Focus on squeezing just the pelvic muscle. Breathe! • Repetition is important, but don't overdo it. When you're first beginning Kegel exercises, find a quiet spot to practice so you can concentrate. Many women choose their bedroom or bathroom. Lie on the floor. Pull in the pelvic muscles and hold for a count of three. Then relax for a count of three. Perform up to 10 to 15 repetitions each time you exercise.
• Do your pelvic exercises at least three times a day. Use three positions every day: lying down, sitting and standing. You can exercise while lying on the floor, sitting at a desk or standing in the kitchen. Using all three positions promotes maximum muscle strengthening. Remember, just 5 mins, three times a day can make a world of difference.
• Be patient. Don't give up. You may not feel your bladder control improve for three to six weeks. Depending on the severity of your condition, however, Kegels may not bring sufficient relief. If symptoms do not improve within three to six weeks, see your doctor.
• Be aware of when you should be using your pelvic muscles. Whenever stress is applied to the bladder (e.g. sneezing, lifting or jumping), the pelvic muscles play a particularly important role. Squeezing the pelvic muscles before engaging in these activities can prevent muscle damage and reduce the frequency of leakage and accidents. 
Pharmacologic options for urge incontinence
Anticholinergics are recommended as the first-line pharmacotherapy in the treatment of urinary incontinence.
Tolerodine and oxybutynin are considered standard therapy, but tolerodine can be first considered for use as a muscarinic receptor antagonist, as it has a higher selectivity to bladder receptors and a lower incidence of adverse effects like headache, fatigue and symptoms involving the gastrointestinal tract and central nervous system. Furthermore, tolerodine has not been associated with significant changes in electrocardiogram, blood pressure, or standard clinical chemistry or haematologic variables. Oxybutynin can cause reduced saliva production and worsening constipation that are severe enough to result in up to one in ten children discontinuing its use.
TA KE H O M E M E S SAG E S
1. There are many investigatory and management options for the varying types and severity of urinary incontinence that can be managed at the primary care level.
2. Clinicians should actively screen for or initiate a discussion on urinary incontinence, which can be underdiagnosed in the community.
3. 
